MIT News

Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

Some tumor cells develop resistance by amplifying the KRAS gene, while others change their tumor type, MIT researchers have found.

作者 MIT News

1 分钟阅读
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs
Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Science & R&D相关内容

相关洞察